SLAS Discovery announces its July feature article, '3D Cell-Based Assays for Drug Screens: Challenges in Imaging, Image Analysis, and High-Content Analysis'

June 24, 2019

Oak Brook, IL - In July's SLAS Discovery feature article, "3D Cell-Based Assays for Drug Screens: Challenges in Imaging, Image Analysis, and High-Content Analysis," Tijmen H. Booij, Ph.D., Screening Specialist for NEXUS Personalized Health Technologies (Switzerland), discusses the switch from using 2D to 3D cell cultures in drug discovery to more accurately mimic human physiological conditions and improve the success rates of drugs in the early stages of preclinical drug discovery.

In traditional target-based discovery, drugs are designed to focus on a single molecular target, whereas phenotypic drug discovery screens cellular systems. The latter strategy could be used as an alternative to pre-select drugs for the clinic, allowing for drug discovery at a target-agnostic level. This approach, however, is mainly used with 2D cell cultures that do not fully represent human physiology and historically has shown to prioritize the wrong drugs. To overcome this limitation, 3D cell cultures have been developed that may more accurately mimic physiological conditions.

In his review, Dr. Booij details the switch from 2D to 3D cell cultures and the challenges for high-throughput screening and high-content analysis. Using high-content analysis with 3D cell cultures in high-throughput screens has long been difficult due to technological limitations, and screens with 3D cell cultures have mostly used simple readouts that limit the amount of information that can be extracted. In addition, there is an enormous range in 3D cell culture techniques that has large consequences for the ease of collecting quality data.

The introduction of more relevant cell models in early preclinical drug discovery, combined with high-content imaging and automated analysis, is expected to increase the quality of compounds progressing to preclinical stages in the drug development pipeline. Overcoming these challenges will enable front-loading the drug discovery pipeline with better biology, extracting the most from that biology and improving translation between in vitro and in vivo models. This is expected to reduce the proportion of compounds that fail in vivo testing due to a lack of efficacy or to toxicity.

Access to July's SLAS Discovery special issue is available at https://journals.sagepub.com/toc/jbxb/24/6 through August 20. For more information about SLAS and its journals, visit http://www.slas.org/journals.
-end-
SLAS (Society for Laboratory Automation and Screening) is an international community of 19,000 professionals and students dedicated to life sciences discovery and technology. The SLAS mission is to bring together researchers in academia, industry and government to advance life sciences discovery and technology via education, knowledge exchange and global community building.

SLAS Discovery: 2017 Impact Factor 2.355. Editor-in-Chief Robert M. Campbell, Ph.D., Eli Lilly and Company, Indianapolis, IN (USA). SLAS Discovery (Advancing Life Sciences R&D) was previously published (1996-2016) as the Journal of Biomolecular Screening (JBS).

SLAS (Society for Laboratory Automation and Screening)

Related Biology Articles from Brightsurf:

Experimental Biology press materials available now
Though the Experimental Biology (EB) 2020 meeting was canceled in response to the COVID-19 outbreak, EB research abstracts are being published in the April 2020 issue of The FASEB Journal.

Structural biology: Special delivery
Bulky globular proteins require specialized transport systems for insertion into membranes.

Cell biology: All in a flash!
Scientists of Ludwig-Maximilians-Universitaet (LMU) in Munich have developed a tool to eliminate essential proteins from cells with a flash of light.

A biology boost
Assistance during the first years of a biology major leads to higher retention of first-generation students.

Cell biology: Compartments and complexity
Ludwig-Maximilians-Universitaet (LMU) in Munich biologists have taken a closer look at the subcellular distribution of proteins and metabolic intermediates in a model plant.

Cell biology: The complexity of division by two
Ludwig-Maximilians-Universitaet (LMU) in Munich researchers have identified a novel protein that plays a crucial role in the formation of the mitotic spindle, which is essential for correct segregation of a full set of chromosomes to each daughter cell during cell division.

Cell biology: Dynamics of microtubules
Filamentous polymers called microtubules play vital roles in chromosome segregation and molecular transport.

The biology of color
Scientists are on a threshold of a new era of color science with regard to animals, according to a comprehensive review of the field by a multidisciplinary team of researchers led by professor Tim Caro at UC Davis.

Kinky biology
How and why proteins fold is a problem that has implications for protein design and therapeutics.

A new tool to decipher evolutionary biology
A new bioinformatics tool to compare genome data has been developed by teams from the Max F.

Read More: Biology News and Biology Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.